54610-73-0

Basic information

• Product Name: 2-FURANCARBOXIMIDAMIDE
• Synonyms: 2-FURANCARBOXIMIDAMIDE;2-Furancarboximidamide(9CI);2-furancarboximidamide(SALTDATA: HCl);furan-5-carboxamidine
• CAS NO: 54610-73-0
• Molecular Formula: C₅H₆N₂O
• Molecular Weight: 110.11
• Product Categories: AMIDINE
• Mol File: 54610-73-0.mol

Chemical Properties

• Boiling Point: 178.9°C at 760 mmHg
• Flash Point: 62°C
• Appearance: /
• Density: 1.3g/cm³
• Vapor Pressure: 0.965mmHg at 25°C
• Refractive Index: 1.585
• PKA: 11.48±0.40(Predicted)
• CAS DataBase Reference: 2-FURANCARBOXIMIDAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-FURANCARBOXIMIDAMIDE(54610-73-0)
• EPA Substance Registry System: 2-FURANCARBOXIMIDAMIDE(54610-73-0)

Safety Data

• Hazardous Substances Data: 54610-73-0(Hazardous Substances Data)

Usage

Uses

Used in Agricultural Industry:
2-Furancarboximidamide is used as a bird repellent for protecting crops from bird damage. It is applied to minimize the impact of birds on agricultural yields, ensuring the protection of crops and contributing to more efficient farming practices.
In order to reduce the chemical's environmental impact and safeguard non-target organisms, it is crucial to employ appropriate precautions during its application. This includes adhering to recommended guidelines and regulations for the use of 2-Furancarboximidamide in agriculture.

InChI:InChI=1/C5H6N2O/c6-5(7)4-2-1-3-8-4/h1-3H,(H3,6,7)

Upstream product

• 617-90-3 2-furancarbonitrile 
• 54610-51-4 Furan-2-carboximidsaeure-aethylester-hydrochlorid 

Downstream Products

• 67945-78-2 (α-amino-furfurylidene)-malononitrile 
• 27568-26-9 2-furan-2-yl-5-phenyl-pyrimidine 
• 35345-16-5 2-furan-2-yl-4-(4-nitro-phenyl)-1⁽³⁾H-imidazole 
• 35345-14-3 4-(4-bromo-phenyl)-2-furan-2-yl-1⁽³⁾H-imidazole 
• 35345-10-9 2-furan-2-yl-4-methyl-1(3)H-imidazole 
• 29916-33-4 2-(furan-2-yl)-4,5-diphenyl-1H-imidazole 
• 27110-82-3 2-(furan-2-yl)pyrimidine 
• 23352-32-1 2-(5-nitro-furan-2-yl)-5-phenyl-pyrimidine 
• 27568-58-7 1-[2-(5-nitro-furan-2-yl)-pyrimidin-5-yloxy]-2-(toluene-4-sulfonyloxy)-ethane 
• 3878-19-1 fuberidazole 
• 3688-57-1 N²-Phenylfuran-2-carboximidamide 
• 59918-48-8 3,6-di(furan-2-yl)-1,2,4,5-tetrazine 
• 104615-18-1 9-chloro-2-(2-furanyl)-[1,2,4]triazolo[1,5-C]quinazolin-5-amine 

Relevant articles and documents

Synthesis of ultrahighly electron-deficient pyrrolo[3,4- d ]pyridazine-5,7-dione by inverse electron demand diels-alder reaction and its application as electrochromic materials

A new electron acceptor 6-alkylpyrrolo[3,4-d]pyridazine-5,7-dione (PPD) with a very low LUMO level has been synthesized via a challenging inverse electron demand Diels-Alder reaction between thiophene and furan-decorated tetrazine substrates and an electron-deficient 1-alkyl-1H-pyrrole-2,5-dione unit. The PPD monomer has been incorporated into a series of donor-acceptor-type conjugated polymers as electrochromic materials with good optical contrast, fast switching speed, and high coloration efficiency.

ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATOR COMPOUNDS AS CANCER THERAPEUTICS

The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of cancers, particularly cancers that exhibit elevated expression of FOXA1 and/or FOXA1 gene targets, such as certain breast, liver and/or prostate cancers, including luminal and/or ER-positive forms of breast cancer. Three previously identified adenosine receptor antagonists, CGS-15943, MRS-1220 and SCH-58261, as well as furan ring moiety-possessing derivatives of CGS-15943 are specifically provided for killing cancer cells in a manner that appears to involve activation of the aryl hydrocarbon receptor (AHR) by such compounds. The instant disclosure therefore provides for selecting and/or administering CGS-15943, MRS-1220, SCH-58261 and/or a furan-possessing derivative of CGS-15943, MRS-1220 and/or SCH-58261 as a therapeutic agent to target a cancer cell and/or subject having or at risk of developing a cancer. Methods and compositions for therapies that include such compounds are also provided

DIPEPTIDYL PEPTIDASE-IV INHIBITING COMPOUNDS, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT

The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.

Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element

Identification of potent and selective inhibitors of inducible nitric oxide synthase (NOS) is of great interest because of their therapeutic potential for treatment of diseases mediated by excess production of nitric oxide. We present here a comparison of